APA (7th ed.) Citation

W, G., W, L., X, L., W, S., Y, Y., T, Y., . . . Y, H. (2026). Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes. Frontiers in endocrinology, 17, 1865769. https://doi.org/10.3389/fendo.2026.1865769

Chicago Style (17th ed.) Citation

W, Guo, Li W, Li X, Shi W, Yan Y, Yan T, Zhou J, and Huang Y. "Effects of SGLT-2 Inhibitors and GLP-1 Receptor Agonists on Liver Function in Patients with Non-alcoholic Fatty Liver Disease and Type 2 Diabetes." Frontiers in Endocrinology 17 (2026): 1865769. https://doi.org/10.3389/fendo.2026.1865769.

MLA (9th ed.) Citation

W, Guo, et al. "Effects of SGLT-2 Inhibitors and GLP-1 Receptor Agonists on Liver Function in Patients with Non-alcoholic Fatty Liver Disease and Type 2 Diabetes." Frontiers in Endocrinology, vol. 17, 2026, p. 1865769, https://doi.org/10.3389/fendo.2026.1865769.